CNR2 and neoplasm: Previous reports showed that exogenous cannabinoids could induce tumor regression [51,52]; one study also demonstrated the anti-tumor activity of CB2 agonists on epidermal cells and that anandamide (a weak CB2 agonist) selectively induces cell death in tumorigenic keratinocytes [53].